Global mouth ulcer treatment market is expected to reach over US $2 billion by 2019, says Technavio

Renewable energy

 

Mouth ulcer treatment: Key market research findings

  • Increased prevalence of mouth ulcers among aging population
  • Shift towards untapped markets for enhanced promotion of generic drugs

Technavio has added a new global market research report on mouth ulcer treatment to its oral hygiene portfolio. The global mouth ulcer treatment market is expected to grow at a CAGR of close to 5% during the forecast period of 2015-2019, owing to the rising public awareness about mouth diseases.

Technavio’s market research analysts predict the Americas to dominate mouth ulcer treatment market due to the augmented use of intra-oral cameras, optical scanners, digital X-rays, and computer assisted designs, in the field of dentistry. This region is expected to account for more than 45% of the total market share and will be closely followed by the EMEA and the APAC regions.

The new industry research report from Technavio discusses in detail the key drivers and trends responsible for growth, as well as the segments with the maximum growth potential.

Around 15%-30% of the global population is affected by the prevalence of mouth ulcers mainly due to trauma, stress, foods, hormonal imbalances, and tobacco smoking. According to the WHO, mouth disorders are common among the aging population. Approximately 2 billion people will be aged 60 years or older by 2050. Higher occurrence of oral ulcers will result in more people seeking treatment, thereby driving the market’s growth.

“Vendors are focusing on emerging markets for better commercialization of mouth ulcer drugs and to extend their customer base. The preference for over-the-counter (OTC) products and their regulatory approval process is gaining traction in these markets. Like, Valeant Pharmaceuticals is concentrating on the marketing of OTC products and generic drugs in Asia, the Middle East, and Latin America. As per the United Nations ESCAP (Social Development Division) market study, over half of the world’s aging population is in APAC, and this number is bound to exceed 1 billion by 2050,” says Imran Mushtaq, Lead Analyst, Healthcare, Technavio Research.

The leading vendors in the global mouth ulcer treatment market are 3M Healthcare, Blistex, Church & Dwight, Taro Pharmaceuticals, and Valeant Pharmaceuticals. The market is highly fragmented due to the presence of numerous local and multinational vendors. The increase in M&A is expected to increase market penetration of drugs that can effectively treat and cure ulcers.

A more detailed analysis is available in the Technavio report, Global Mouth Ulcer Treatment – Market Study 2015-2019.

https://www.technavio.com/%3Cp%3E%3Cu%3E%3Cstrong%3EWe%20can%20customize%…